Thrombocytopenia, inherited as a dominant trait, was present in three generations of a kindred. The clinical picture was quite similar to that of idiopathic thrombocytopenic purpura, but ...
Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...
Blood platelets are anucleated cell fragments derived from highly polyploid, mature bone marrow (BM) megakaryocytes (MKs) that convert their cytoplasm by a cytoskeleton-driven process into long ...
To evaluate the in vivo impact of ibrutinib on platelet aggregation, we performed LTA testing in subjects receiving stable ibrutinib therapy. Human Ethics Research Committee approved platelet studies ...
Clopidogrel is often the antiplatelet agent of choice for patients with ACS or those receiving a stent because, as a generic, it is inexpensive and, as a drug that has been around for a long time, it ...
Barcelona, Spain - 27 Aug 2017: PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis, according to research presented at ESC Congress today.1 The findings suggest ...
Study of the bleeding tendency in uremia in 26 subjects, 10 of whom were bleeding, showed platelet counts and plasma coagulation factors to be normal. There was a significant inverse correlation ...
LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...
Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The use of platelet-function tests to monitor and guide antiplatelet therapy in ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Patients on prasugrel therapy have greater platelet inhibition than those taking maintenance doses of clopidogrel and thus require a longer time to return to baseline reactivity after stopping the ...
The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback